Niopam (Iopamidol)

Niopam (iopamidol) is employed as a radiographic contrast medium to enhance visualization of vascular and tissue structures during imaging procedures.

• X‑ray/CT imaging: Improves delineation of anatomical structures and lesions, aiding diagnostic accuracy.
• Angiography: Highlights blood vessels to facilitate assessment of vascular patency and pathology.
• Urography: Enhances visualization of the urinary tract for detection of obstruction or disease.
• Myelography: Provides contrast within the spinal canal to assist evaluation of the spinal cord and nerve roots.

• Iopamidol contains multiple iodine atoms that strongly absorb X‑ray photons, increasing the attenuation of the X‑ray beam as it passes through tissues. After intravenous or intra‑arterial injection, the agent distributes rapidly within the extracellular fluid, creating a high‑density contrast between blood, organs and surrounding structures. Its non‑ionic, low‑osmolality formulation reduces osmotic stress on cells, allowing effective imaging with a lower incidence of adverse reactions compared with high‑osmolality agents.

Adverse reactions to iodinated contrast agents may vary in frequency and severity.

Common Side Effects

• Warm sensation or flushing at injection site.
• Metallic taste or mild nausea.
• Headache or transient dizziness.
• Mild urticaria or itching.

Serious or Rare Side Effects

• Severe allergic reaction or anaphylaxis.
• Acute kidney injury or contrast‑induced nephropathy.
• Hypotension or cardiovascular collapse.
• Pulmonary edema or respiratory distress.

Prior to administration, specific safety measures should be observed to minimize risk.

• Assess renal function: evaluate serum creatinine and eGFR before use.
• Review allergy history: identify prior reactions to iodinated contrast or related agents.
• Use lowest effective dose: tailor volume to imaging requirement and patient size.
• Monitor vital signs: observe blood pressure and heart rate during and after injection.
• Avoid in patients with known hypersensitivity to iodinated contrast agents.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Iopamidol may interact with other medicines, influencing safety or efficacy.

Major Interactions (Avoid)

• Concurrent administration of other iodinated contrast agents: cumulative iodine load may increase toxicity.
• Nephrotoxic drugs (e.g., aminoglycosides, high‑dose NSAIDs): heightened risk of renal impairment.
• Metformin in patients with reduced renal function: risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask tachycardia that signals an adverse reaction.
• Diuretics: can affect fluid balance and renal clearance of contrast.
• Thyroid hormone therapy: excess iodine may alter thyroid function tests.
• ACE inhibitors or ARBs: may increase susceptibility to contrast‑induced nephropathy.